Sector: Pharmaceuticals & Biotechnology

Small Cap

Pharmaids Pharma Share Price

Q: What is the Market Capitalization of Pharmaids Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Pharmaids Pharmaceuticals Ltd. is approximately ₹ 127 Cr.

Q: What are the PE and PB ratios for Pharmaids Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Pharmaids Pharmaceuticals Ltd. is -10.8, and the Price-to-Book (PB) ratio is 2.7.

Q: What is the 52-Week High and Low for Pharmaids Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Pharmaids Pharmaceuticals Ltd. shares was ₹ 70, and the lowest price was ₹ 25.6.

Q: Who are the major shareholders of Pharmaids Pharmaceuticals Ltd.?

Significant shareholdings in Pharmaids Pharmaceuticals Ltd. typically include entities such as: Public Promoter Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Pharmaids Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Pharmaids Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Pharmaids Pharmaceuticals Ltd.

₹36

1.69(4.93%)

25th Jun 2026 | 3:24 PM

NSE :

Open Free Demat Account

Pharmaids Pharma Performance

Price Movement

N/A

₹34.20

₹38.90

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹38.90

Low₹34.20

Open at₹34.20

Prev Close₹34.31

Volumes30.24 K

Avg Price₹37.02

Lower Circuit₹30.31

Upper Circuit₹45.45

Historical Performance

3M High₹39.87

3M Low₹25.60

1 Yr High₹70.00

1 Yr Low₹25.60

3 Yr High₹87.46

3 Yr Low₹25.60

5 Yr High₹87.46

5 Yr Low₹10.17

Summary

As of 26-06-2026 03:07, Pharmaids Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-34.31 (-100.00%) from the previous close of ₹34.31. The stock opened at ₹34.2 and traded between ₹34.2 and ₹38.9, with a total traded volume of 30242 shares. The company has a market capitalization of ₹127 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹70 and ₹25.6, respectively.

Pharmaids Pharmaceuticals Ltd. valuation metrics include a P/E ratio of -10.8, EPS of ₹-3.31, and book value of ₹2.70. Profitability indicators show ROE of -24.58%. Pharmaids Pharmaceuticals Ltd. has reported revenue of ₹27.88 Cr and net profit of ₹-11.72 Cr.

Pharmaids Pharmaceuticals Ltd. technical indicators include Day RSI at 71.33, Day MFI at 89.52, Day ADX at 28.91. Additional indicators include Commodity Channel Index (CCI) at 170.8 and Williams %R at -14.35. Momentum indicators show Day MACD at 1.62, Day MACD Signal Line at 0.67, DayATR at 3.07. Rate of Change indicators for Pharmaids Pharmaceuticals Ltd. include ROC125 at -24.26 and ROC21 at 33.05.

Exponential moving averages include EMA5 at ₹35, EMA10 at ₹33.2, EMA12 at ₹32.7, EMA20 at ₹31.5, EMA26 at ₹31.1, EMA50 at ₹31, EMA100 at ₹33.8, EMA200 at ₹39.9. Simple moving averages include SMA5 at ₹34.7, SMA10 at ₹32.6, SMA20 at ₹30.2, SMA30 at ₹29.9, SMA50 at ₹30.1, SMA100 at ₹32.4, SMA150 at ₹37.5, SMA200 at ₹41.4.

Support levels for Pharmaids Pharma are placed at First Support ₹35.09, Second Support ₹32.29, Third Support ₹30.39. Resistance levels are seen at First Resistance ₹39.79, Second Resistance ₹41.69, Third Resistance ₹44.49. Pharmaids Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 32.99%, FII holding at 0%, DII holding at 0%, public holding at 67%.

Pharmaids Pharma Fundamentals

Market Cap

Below industry Median

127 Cr.

PE Ratio (TTM)

Negative PE TTM

-10.80

Dividend Yield

Net Profit TTM

9% decr over last year

-11.72

Net Profit Growth

9% decr over last year

-11.72

PEG Ratio

Above industry Median

1.20

ROE

35% decr over last year

-24.58

Operating Revenue TTM

27.88

Operating Revenue Growth

43.8% incr over last year

Book Value

Below industry Median

2.70

MFI

MFI strongly Overbought

89.52

RSI

RSI Overbought

71.33

EPS (TTM)

-3.31

Debt to Equity

0.44

Face Value

Operating Profit Margin Qtr.

-48.06

Operating Profit Qtr.

-0.34

Net Profit Qtr.

-1.81

Operating Revenue Qtr.

7.18

PB Ratio

2.70

Pharmaids Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	2.69	0.83	5.97	1.12	0.13
Operating Expense	3.77	4.51	10.54	5.99	2.81
Operating Profit	-1.08	-3.67	-4.58	-4.88	-2.68
Depreciation	0.05	0.05	0.06	0.05	0.05
Interest	0.60	0.57	1.02	1.11	2.05
Tax	-0.38	-1.13	-0.68	-1.33	-0.72
Net Profit	-1.31	-3.11	-1.65	-4.36	-3.06

Pharmaids Pharma Technicals

Pharmaids Pharmaceuticals Ltd. EMA & SMA

₹36.00

1.69 (4.93%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹35

Day EMA10 ₹33.2

Day EMA12 ₹32.7

Day EMA20 ₹31.5

Day EMA26 ₹31.1

Day EMA50 ₹31

Day EMA100 ₹33.8

Day EMA200 ₹39.9

Pharmaids Pharma Support and Resistance

Resistance

First Resistance₹39.79

Second Resistance₹41.69

Third Resistance₹44.49

Support

First Support₹35.09

Second Support₹32.29

Third Support₹30.39

Technical Indicators

Day RSI71.33

Day MFI89.52

Day ADX28.91

Day Commodity Channel Index170.80

William-14.35

Day MACD1.62

Day MACD Signal Line0.67

Day ATR3.07

Day ROC125-24.26

Day ROC2133.05

Pharmaids Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	5.2	5.2	5.1	33	33	33
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	94.8	94.8	94.9	0	67	67

Pharmaids Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	22.54 K	30.24 K	74.52%
Week	19.5 K	39.22 K	49.72%
1 Month	16.09 K	26.4 K	60.94%
6 Month	10.35 K	13.7 K	75.53%

Pharmaids Pharma SWOT Analysis

Strengths20

Weakness6

Opportunity1

Threats1

Companies with 10% increase in share price over three months, with rising net profit growth

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Stocks whose current price is 20% higher than week low, and more than previous close

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Companies with reducing Debt

Increasing profits every quarter for the past 3 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

Stock with Low PE (PE < = 10)

RSI indicating price strength

Biggest Price Gainers from Open

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Pharmaids Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Pharmaids Pharma Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹43.20	₹588	₹201	₹258.80	₹35.50	₹5.70
% Change	-3.76%	-0.30%	-1.95%	-2.34%	-1.33%	-1.04%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	10.10	-	13.50	37.00	-84.00	-1.40
1 Year Return		49.31			688.89	471
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 235.15

+0.73%

AMANTA

Amanta Healthcare Ltd.

₹ 162.00

-0.52%

AHCL

Anlon Healthcare Ltd.

₹ 16.37

+1.49%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 93.60

+1.15%

APL

Asston Pharmaceuticals Ltd.

₹ 81.00

-1.22%

UNICHEMLAB

Unichem Laboratories Ltd.

₹ 432.60

-0.22%

FERMENTA

Fermenta Biotech Ltd.

₹ 364.25

-0.26%

GENPHARMA

Genpharmasec Ltd.

₹ 1.11

-2.63%

KILITCH

Kilitch Drugs(I) Ltd.

₹ 185.00

-3.05%

MEDICO

Medico Remedies Ltd.

₹ 40.00

-2.56%

CONCORD

Concord Drugs Ltd.

₹ 76.40

+1.61%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 305.80

-1.61%

KIMIABL

Kimia Biosciences Ltd.

₹ 33.74

+4.88%

CORALAB

Coral Laboratories Ltd.

₹ 625.00

-3.52%

JENBURPH

Jenburkt Pharmaceuticals Ltd.

₹ 1126.60

-0.13%

KPL

Kwality Pharmaceuticals Ltd.

₹ 2436.70

-0.54%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 228.00

-0.61%

GVBL

Genomic Valley Biotech Ltd.

₹ 33.36

-4.98%

UNJHAFOR

Unjha Formulations Ltd.

₹ 19.00

+0.00%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.48

-0.52%

ANG

ANG Lifesciences India Ltd.

₹ 42.21

+1.93%

BROOKS

Brooks Laboratories Ltd.

₹ 73.20

-4.69%

FAQ's on PHARMAID

What is the Market Capitalization of Pharmaids Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Pharmaids Pharmaceuticals Ltd. is approximately ₹ 127 Cr.

What are the PE and PB ratios for Pharmaids Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Pharmaids Pharmaceuticals Ltd. is -10.8, and the Price-to-Book (PB) ratio is 2.7.

What is the 52-Week High and Low for Pharmaids Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Pharmaids Pharmaceuticals Ltd. shares was ₹ 70, and the lowest price was ₹ 25.6.

Who are the major shareholders of Pharmaids Pharmaceuticals Ltd.?

Significant shareholdings in Pharmaids Pharmaceuticals Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Pharmaids Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Pharmaids Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy